Name Net increased
positions
Increased positions Reduced positions Return since
30 Jun ‘21
476
4 7 3 54.6%
477
4 27 23 95.7%
478
4 11 7 30%
IKT icon
479
Inhibikase Therapeutics
IKT
$248M
4 4 0 88.8%
480
4 6 2 86.8%
481
4 6 2 22.4%
482
4 7 3 93.3%
483
4 27 23 43.7%
484
4 11 7 82%
485
4 11 7 9.68%
EUDG icon
486
WisdomTree Europe Quality Dividend Growth Fund
EUDG
$70.5M
4 11 7 13.2%
487
4 7 3 51.1%
488
4 11 7 100%
489
4 6 2 96.8%
490
4 26 22 23.5%
491
4 10 6 52%
492
4 18 14 83.1%
493
4 4 0 100%
494
4 9 5 96.7%
495
4 15 11 88.7%
496
4 7 3 99.5%
497
4 16 12 56.7%
498
4 7 3 39.6%
499
4 14 10 100%
500
4 18 14 89.7%